Bupa has launched a new DNA testing service designed to identify how individuals respond to common prescription medications, following a pilot which found that 99% of participants had a genetic sensitivity to at least one drug. Medication Check, which is available to purchase for £300 via Bupa’s website, analyses a saliva sample to assess how…
Membership Required
You must be a HM Subscriber to view this content.
Previous articleHealthcare spending: the widening gap between cost and capabilities 
Maria has more than two decades’ experience as a business and financial journalist. She has specialised in writing about the UK’s private and voluntary healthcare sector for the last 15 years. Maria covered the historic ‘Condordat’ signed by the NHS and independent healthcare providers, which paved the way for the Labour government’s radical market-based reform of the NHS at the turn of the Millennium. Since then, she has tracked the key trends in independent healthcare from the advent of patient choice and the emerging NHS market to multi-million pound flotations and game-changing deals.